Suppr超能文献

[病理肿瘤体积预测局部晚期声门癌患者的生存结局]

[Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].

作者信息

Gong Hongli, Zhou Liang, Tao Lei, Zhang Ming, Wu Haitao, Chen Xiaoling, Li Xiaoming, Li Cai, Zhou Jian

机构信息

Department of Otolaryngology Head and Neck Surgery,Eye & ENT Hospital of Fudan University,Shanghai,200031,China.

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Apr;35(4):316-320. doi: 10.13201/j.issn.2096-7993.2021.04.007.

Abstract

The aim of this study was to evaluate the predicting role of tumor volume as evaluated by postoperative pathologic examination on overall survival(OS) and disease free survival(DFS) in patients with local advanced glottic carcinoma. In this study, the records of 406 consecutive patients with local advanced glottic carcinoma(T3-T4 stages) who underwent surgery ± chemoradiotherapy from January 2005 to December 2010 were retrospectively reviewed and followed up. The demographic characteristics, disease staging, and pathologic tumor volume were analyzed. The optimal cutoff values of tumor volume for OS and DFS were obtained by using receiver operating characteristic(ROC) curves. The association of tumor volume with T stages were assessed by using Logistic regression model, and the relationship between tumor volume and OS and DFS rates were evaluated by using Cox regression models. The 5-and 10-year OS rates were 62.9% and 55.4%, respectively. The 5-and 10-year DFS rates were 55.5% and 50.8%, respectively. The mean tumor volume was(5.1±6.7) cm³, T4 stage patients had higher tumor volume than those of patients with T3 stage(<0.001). The factor of tumor volume was correlated with T stages by using Logistic regression analyses(=13.81, 95%: 6.03-31.59, <0.001). The optimal cutoff values of tumor volume that were both at 3 cm³ for OS and DFS rates were obtained by using ROC curve plots. The OS and DFS rates of glottic carcinoma patients with tumor volume ≤ 3 cm³ were better when compared with those of patients with tumor volume>3 cm³(<0.001). Upon multivariate analyses, tumor volume was strongly correlated with poorer OS and DFS rates and remained independent prognostic factors for both the OS and DFS of patients with glottic carcinoma(OS: =1.59, 95%: 1.09-2.32, =0.017; DFS: =1.54, 95%: 1.08-2.20, =0.016). This study demonstrates that tumor volume is correlated with T stages, and this factor is an independent predictive factor of survival outcomes in patients with local advanced glottic carcinoma.

摘要

本研究旨在评估术后病理检查所评估的肿瘤体积对局部晚期声门癌患者总生存期(OS)和无病生存期(DFS)的预测作用。在本研究中,回顾性分析并随访了2005年1月至2010年12月期间连续406例行手术±放化疗的局部晚期声门癌(T3 - T4期)患者的记录。分析了患者的人口统计学特征、疾病分期和病理肿瘤体积。通过绘制受试者工作特征(ROC)曲线得出OS和DFS的肿瘤体积最佳截断值。采用Logistic回归模型评估肿瘤体积与T分期的相关性,采用Cox回归模型评估肿瘤体积与OS及DFS率之间的关系。5年和10年OS率分别为62.9%和55.4%。5年和10年DFS率分别为55.5%和50.8%。平均肿瘤体积为(5.1±6.7)cm³,T4期患者的肿瘤体积高于T3期患者(<0.001)。通过Logistic回归分析,肿瘤体积因素与T分期相关(=13.81,95%置信区间:6.03 - 31.59,<0.001)。通过ROC曲线绘制得出OS和DFS率的肿瘤体积最佳截断值均为3 cm³。肿瘤体积≤3 cm³的声门癌患者的OS和DFS率优于肿瘤体积>3 cm³的患者(<0.001)。多因素分析显示,肿瘤体积与较差的OS和DFS率密切相关,并且仍然是声门癌患者OS和DFS的独立预后因素(OS:=1.59,95%置信区间:1.09 - 2.32,=0.017;DFS:=1.54,95%置信区间:1.08 - 2.20,=0.016)。本研究表明,肿瘤体积与T分期相关,并且该因素是局部晚期声门癌患者生存结局的独立预测因素。

相似文献

1
[Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Apr;35(4):316-320. doi: 10.13201/j.issn.2096-7993.2021.04.007.
2
Pathologic Tumor Size as a Predictor of the Survival Outcomes of Patients With Glottic Carcinoma.
Otolaryngol Head Neck Surg. 2021 Feb;164(2):353-358. doi: 10.1177/0194599820937296. Epub 2020 Jul 7.
3
Importance of tumor volume in supraglottic and glottic laryngeal carcinoma.
Strahlenther Onkol. 2013 Dec;189(12):1009-14. doi: 10.1007/s00066-013-0467-2. Epub 2013 Nov 8.
4
Preoperative tracheotomy as reflection of tumor size impacting oncologic outcomes of patients with advanced stage glottic carcinoma.
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4943-4950. doi: 10.1007/s00405-021-06721-9. Epub 2021 Mar 6.
5
Predictive value of pathological carcinoma size in patients with T2 glottic laryngeal squamous cell carcinoma.
Acta Otolaryngol. 2023 Apr;143(4):317-321. doi: 10.1080/00016489.2023.2188083. Epub 2023 Mar 30.
6
Prognostic value of pathological tumor size in patients with supraglottic carcinoma.
Am J Otolaryngol. 2021 Jan-Feb;42(1):102757. doi: 10.1016/j.amjoto.2020.102757. Epub 2020 Oct 19.
8
Low expression of pRB predicts disease relapse in early glottic cancer treated with transoral laser microsurgery.
Laryngoscope. 2019 Jun;129(6):E220-E226. doi: 10.1002/lary.27612. Epub 2018 Nov 1.
9
Tumor volume as a prognostic factor of locally advanced laryngeal cancer.
Eur Arch Otorhinolaryngol. 2021 May;278(5):1627-1635. doi: 10.1007/s00405-020-06438-1. Epub 2020 Oct 23.

引用本文的文献

1
[Development and validation of nomogram for predicting prognosis of patients with laryngeal squamous cell carcinoma after surgery].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Dec;36(12):902-909. doi: 10.13201/j.issn.2096-7993.2022.12.003.

本文引用的文献

1
[Progress in CT and MRI of preoperative T staging of laryngeal carcinoma].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 May;34(5):470-474. doi: 10.13201/j.issn.2096-7993.2020.05.022.
2
[The progress on diagnosis and treatment of larynx cancer].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Nov;33(11):1017-1021. doi: 10.13201/j.issn.1001-1781.2019.11.003.
3
[Treatment options for advanced laryngeal carcinoma].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 May 7;54(5):398-400. doi: 10.3760/cma.j.issn.1673-0860.2019.05.018.
4
Incidence and mortality of laryngeal cancer in China, 2008-2012.
Chin J Cancer Res. 2018 Jun;30(3):299-306. doi: 10.21147/j.issn.1000-9604.2018.03.02.
5
[Significance of induction chemotherapy in the treatment of locally advanced laryngeal cancer and hypopharyngeal cancer].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Oct 5;30(19):1548-1551. doi: 10.13201/j.issn.1001-1781.2016.19.011.
6
Tumor volume as a predictor of survival in T3 glottic carcinoma: A novel approach to patient selection.
Oral Oncol. 2018 Apr;79:47-54. doi: 10.1016/j.oraloncology.2018.02.015. Epub 2018 Feb 22.
8
Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1701-1711. doi: 10.1007/s00405-016-4411-9. Epub 2016 Dec 10.
9
Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands.
Head Neck. 2016 Apr;38 Suppl 1:E1247-55. doi: 10.1002/hed.24200. Epub 2015 Aug 28.
10
Survival outcomes in advanced laryngeal cancer.
JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):855-60. doi: 10.1001/jamaoto.2014.1671.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验